XML 18 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Cash Flows from Operating Activities:    
Net income $ 13,773 $ 20,570
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation expense, intangible asset and other amortization 4,894 3,009
Stock-based compensation 9,490 6,658
Excess tax benefit from stock-based compensation 0 (164)
Amortization of deferred commissions 1,072 1,365
Payments of deferred commissions (1,389) (921)
Equity in earnings of equity method investments (679) (201)
Realized gain on sale of equity method investment 0 (2,883)
Sales of trading securities, net 5,558 11,122
Deferred taxes, net (576) 7,190
Changes in operating assets and liabilities:    
Accounts receivable, net and other assets (7,359) 576
Accrued compensation and benefits, accounts payable, accrued liabilities and other liabilities (22,465) (25,430)
Operating activities of consolidated investment products (CIP):    
Net cash provided by operating activities 54,632 51,945
Cash Flows from Investing Activities:    
Capital expenditures (678) (1,093)
Proceeds from sale of equity method investment 0 8,621
Equity method investment contributions 0 (759)
Acquisition of business (cash paid $471.4 million, less cash acquired $77.6 million) (393,784) 0
Purchases of available-for-sale securities (130) (121)
Net cash (used in) provided by investing activities (389,126) 6,751
Cash Flows from Financing Activities:    
Issuance of debt 260,000 0
Repayments on credit facility and other debt (30,271) 0
Payment of deferred financing costs (15,520) 0
Proceeds from issuance of mandatory convertible preferred stock, net of issuance costs 111,004 0
Proceeds from issuance of common stock, net of issuance costs 109,487 0
Common stock dividends paid (6,060) (7,638)
Preferred stock dividends paid (2,084) 0
Repurchases of common shares 0 (61,809)
Proceeds from exercise of stock options 86 400
Taxes paid related to net share settlement of restricted stock units (3,029) (1,332)
Excess tax benefits from stock-based compensation 0 164
Contributions of noncontrolling interests, net 7,733 1,537
Net cash provided by financing activities 430,846 91,590
Net increase in cash and cash equivalents 96,352 150,286
Cash and cash equivalents, beginning of period 82,687 97,384
Cash and Cash Equivalents, End of Period 179,039 247,670
Non-Cash Investing Activities:    
Change in accrual for capital expenditures (174) 45
Non-Cash Financing Activities:    
Decrease to noncontrolling interest due to deconsolidation of consolidated investment products 11,286 (52,874)
Stock issued for acquisition of business 21,738 0
Contingent consideration for acquisition of business 51,690 0
Common stock dividends payable 3,248 3,473
Preferred stock dividends payable 2,084 0
Accrued stock issuance costs 334 0
Consolidated entity excluding consolidated investment products    
Adjustments to reconcile net income to net cash provided by operating activities:    
Realized and unrealized (gains) losses on trading securities, net (1,584) 260
Cash Flows from Financing Activities:    
Cash and cash equivalents, beginning of period 64,588  
Cash and Cash Equivalents, End of Period 127,571  
Consolidated investment products    
Adjustments to reconcile net income to net cash provided by operating activities:    
Realized and unrealized (gains) losses on trading securities, net (2,879) (6,364)
Operating activities of consolidated investment products (CIP):    
Purchases of investments by CIP (150,500) (334,459)
Sales of investments by CIP 205,347 356,437
Net purchases of short term investments by CIP 265 6,515
Sales (purchases) of securities sold short by CIP, net 153 (4,455)
Change in cash pledged or on deposit of CIP 130 9,582
Change in other assets of CIP 1,589 (585)
Change in liabilities of CIP (208) 404
Amortization of discount on notes payable of CIP 0 3,719
Cash Flows from Investing Activities:    
Change in cash and cash equivalents of consolidated investment products due to consolidation, net 5,466 103
Cash Flows from Financing Activities:    
Repayment of debt of CIP 0 (156,012)
Proceeds from issuance of notes payable by CIP 0 316,280
Repayment of notes payable by CIP (500) $ 0
Cash and cash equivalents, beginning of period 18,099  
Cash and Cash Equivalents, End of Period $ 51,468